Wei-Chiao Chang Selected Research

Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)

11/2017	CYP2E1 Gene Polymorphisms Related to the Formation of Coronary Artery Lesions in Kawasaki Disease.
10/2017	Prediction for Intravenous Immunoglobulin Resistance by Using Weighted Genetic Risk Score Identified From Genome-Wide Association Study in Kawasaki Disease.
8/2017	Correlation of HAMP gene polymorphisms and expression with the susceptibility and length of hospital stays in Taiwanese children with Kawasaki disease.
4/2016	Interferon-gamma Genetic Polymorphism and Expression in Kawasaki Disease.
2/2016	Intravenous immunoglobulin, pharmacogenomics, and Kawasaki disease.
1/2015	FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease.
4/2014	Association between Kawasaki disease and autism: a population-based study in Taiwan.
1/2013	A replication study for association of ITPKC and CASP3 two-locus analysis in IVIG unresponsiveness and coronary artery lesion in Kawasaki disease.
12/2012	Comparison of the laboratory data between Kawasaki disease and enterovirus after intravenous immunoglobulin treatment.
8/2012	Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei-Chiao Chang Research Topics

Disease

38	Neoplasms (Cancer) 03/2023 - 11/2011
14	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 11/2017 - 02/2011
12	Inflammation (Inflammations) 01/2022 - 06/2011
9	Neoplasm Metastasis (Metastasis) 01/2023 - 11/2011
8	Infections 12/2022 - 12/2012
7	Fibrosis (Cirrhosis) 01/2021 - 09/2012
6	Ankylosing Spondylitis 05/2024 - 01/2011
6	Lung Neoplasms (Lung Cancer) 01/2021 - 07/2011
5	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 06/2013
5	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2014
5	Breast Neoplasms (Breast Cancer) 12/2020 - 11/2011
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2015 - 03/2002
4	Hypersensitivity (Allergy) 05/2024 - 01/2013
4	Osteoporosis 05/2023 - 01/2020
4	Chronic Renal Insufficiency 01/2021 - 01/2012
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2011
4	Nephrolithiasis 11/2019 - 01/2011
4	Carcinoma (Carcinomatosis) 03/2015 - 11/2011
3	IGA Glomerulonephritis (IGA Nephropathy) 02/2024 - 04/2020
3	Anemia 04/2021 - 08/2012
3	Renal Insufficiency (Renal Failure) 04/2021 - 09/2017
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 11/2020
3	COVID-19 01/2021 - 01/2020
3	Chronic Hepatitis B 01/2021 - 12/2019
3	Stomach Neoplasms (Stomach Cancer) 11/2019 - 03/2015
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 07/2017
3	Carcinogenesis 12/2018 - 01/2012
3	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 12/2014
3	Glioma (Gliomas) 01/2018 - 12/2014
3	Atherosclerosis 11/2017 - 05/2011
2	Asthma (Bronchial Asthma) 01/2022 - 01/2022
2	Hyperaldosteronism (Conn Syndrome) 01/2022 - 01/2021
2	Kidney Diseases (Kidney Disease) 07/2021 - 04/2020
2	Stroke (Strokes) 01/2021 - 01/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2014
2	Brain Concussion (Cerebral Concussion) 12/2019 - 01/2018
2	Adenocarcinoma 11/2019 - 12/2015
2	Disease Progression 10/2019 - 01/2019
2	Aneurysm (Aneurysms) 08/2017 - 04/2016
2	Endometrial Neoplasms (Endometrial Cancer) 02/2016 - 03/2015
2	Triple Negative Breast Neoplasms 02/2016 - 01/2014
2	Cystitis 08/2015 - 11/2013

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2016
10	CalciumIBA 12/2020 - 01/2011
10	Intravenous Immunoglobulins (IVIG)FDA Link 10/2017 - 01/2012
9	Proteins (Proteins, Gene)FDA Link 07/2021 - 07/2011
6	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2024 - 07/2017
6	RNA (Ribonucleic Acid)IBA 03/2023 - 01/2017
6	CytokinesIBA 01/2021 - 11/2011
6	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2019 - 07/2011
5	Calcium Channels (Calcium Channel)IBA 01/2022 - 05/2011
5	ChemokinesIBA 01/2021 - 11/2013
5	Stromal Interaction Molecule 1IBA 01/2021 - 01/2012
5	MicroRNAs (MicroRNA)IBA 06/2020 - 05/2011
5	ErbB Receptors (EGF Receptor)IBA 09/2015 - 01/2012
5	Epidermal Growth Factor (EGF)IBA 04/2015 - 12/2011
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 06/2013
4	Hormones (Hormone)IBA 12/2019 - 06/2012
4	Messenger RNA (mRNA)IBA 01/2017 - 01/2014
4	Transcription Factors (Transcription Factor)IBA 08/2015 - 01/2012
3	Raloxifene Hydrochloride (Evista)FDA Link 05/2023 - 01/2020
3	Diphosphonates (Bisphosphonates)IBA 05/2023 - 01/2022
3	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2018 - 11/2011
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 08/2015 - 06/2013
3	InterleukinsIBA 03/2015 - 04/2012
3	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2015 - 01/2011
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2014 - 08/2013
2	LipidsIBA 05/2024 - 12/2011
2	Immunoglobulin A (IgA)IBA 02/2024 - 04/2020
2	Denosumab FDA Link 05/2023 - 01/2022
2	Teriparatide (Parathar)FDA Link 05/2023 - 01/2022
2	VaccinesIBA 03/2023 - 01/2020
2	Immunoglobulins (Immunoglobulin)IBA 12/2022 - 09/2013
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2018
2	Erythropoietin FDA Link 04/2021 - 07/2017
2	InterferonsIBA 01/2021 - 04/2016
2	LigandsIBA 01/2021 - 11/2013
2	NucleotidesIBA 12/2020 - 02/2016
2	Insulin-Like Growth Factor I (IGF-1)IBA 12/2019 - 01/2017
2	Insulin-Like PeptidesIBA 12/2019 - 01/2017
2	Calcium-Sensing ReceptorsIBA 11/2019 - 01/2011
2	Endothelins (Endothelin)IBA 01/2019 - 09/2017
2	Inflammation MediatorsIBA 01/2016 - 06/2011
2	IonsIBA 09/2015 - 06/2011
2	Ketamine FDA LinkGeneric 08/2015 - 11/2013
2	Fibronectins (Fibronectin)IBA 04/2015 - 09/2012
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 03/2015 - 02/2015
2	Estrogens (Estrogen)FDA Link 03/2015 - 02/2013
2	Interleukin-8 (Interleukin 8)IBA 03/2015 - 06/2013
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 03/2015 - 02/2015
2	Environmental Pollutants (Pollutants, Environmental)IBA 03/2015 - 01/2011
2	Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA 01/2014 - 10/2013
2	Cisplatin (Platino)FDA LinkGeneric 01/2014 - 10/2013
2	Estrogen ReceptorsIBA 01/2014 - 01/2012
2	Matrix Metalloproteinases (MMPs)IBA 08/2013 - 05/2011

Therapy/Procedure

16	Therapeutics 01/2022 - 12/2012
4	Drug Therapy (Chemotherapy) 01/2021 - 01/2014
3	Immunotherapy 03/2023 - 12/2019
2	Biological Therapy 12/2023 - 01/2019
2	Chemoprevention 01/2018 - 08/2013